TNM staging

TNM staging is the shared language doctors use to describe how far a cancer has progressed, built from three simple questions. T asks how big and how invasive the main Tumor is; N asks whether nearby lymph Nodes are involved; and M asks whether the cancer has Metastasized to distant sites. Combine the three letters and you get an overall stage, usually numbered I through IV.

Each letter gets a number that grades severity — for example T1 to T4 by size and local spread, N0 to N3 by which nodes are affected and how far from the tumor they sit, and M0 or M1 for absence or presence of distant spread. A pathologist's tissue findings and the radiologist's scans both feed into these numbers, and a small prefix (c for clinical, before treatment, or p for pathological, after surgery) records how the stage was determined.

Staging matters enormously because it drives the treatment plan and gives a realistic sense of prognosis. Early-stage (I to II) lung cancers are often treated with the goal of cure through surgery or radiation; stage III is a complex middle ground often needing combined treatments; stage IV usually means systemic therapy aimed at control rather than cure. The same staging framework lets clinicians worldwide compare results.

A caveat to keep in mind: the system is periodically updated as evidence accumulates, so a stage assigned under an older edition may not map exactly onto the current one.